Abstract
For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Mini-Reviews in Organic Chemistry
Title:Lichen Depsidones as Potential Novel Pharmacologically Active Compounds
Volume: 9 Issue: 2
Author(s): Gordana Stojanovic, Igor Stojanovic and Andrija Smelcerovic
Affiliation:
Keywords: Biological activity, biosynthesis, depsidones, lichen, structure-activity relationship, Cyrenespora cassiicola, Garcinisidones, M14 cell line, Vicanicin, Lobaric acid
Abstract: For centuries, lichens have been used in traditional medicine and their use persists to the present day in some parts of the world. Depsidones are one of the classes of secondary metabolites which are mostly produced in lichens. Lichen depsidones have been reported to possess many biological activities, such as antitumor and antimicrobial activities. In order to point out the pharmacological potential of this class of compounds, the present article reviews the structure and biological properties of the known lichen depsidones. The biosynthesis of depsidones and the relationship between their chemical structure and biological activity is also discussed.
Export Options
About this article
Cite this article as:
Stojanovic Gordana, Stojanovic Igor and Smelcerovic Andrija, Lichen Depsidones as Potential Novel Pharmacologically Active Compounds, Mini-Reviews in Organic Chemistry 2012; 9 (2) . https://dx.doi.org/10.2174/157019312800604689
DOI https://dx.doi.org/10.2174/157019312800604689 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Repurposing in Chemical Genomics: Can We Learn from the Past to Improve the Future?
Current Topics in Medicinal Chemistry Therapeutic Polycomb Targeting in Human Cancer
Recent Patents on Regenerative Medicine Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Human Leukemia and Lymphoma Cell Lines as Models and Resources
Current Medicinal Chemistry Vitamin D and Lung Cancer
Current Respiratory Medicine Reviews Pharmacotherapy in Systemic Lupus Erythematosus
Current Rheumatology Reviews Flt3 Receptor Tyrosine Kinase as a Drug Target in Leukemia
Current Pharmaceutical Design Electrochemical Indicators for DNA Electroanalysis
Current Analytical Chemistry Pharmacogenetics of Oxazaphosphorines and its Clinical Implications
Current Pharmacogenomics Recent Advances in Regulatory T Cell Therapy of Autoimmunity, Graft Rejection and Cancer
Recent Patents on Inflammation & Allergy Drug Discovery Small Molecule Aurora Kinases Inhibitors
Current Medicinal Chemistry Lymphatic Delivery of Anti-HIV Drug Nanoparticles
Recent Patents on Nanotechnology Role of Active Drug Transporters in Refractory Multiple Myeloma
Current Topics in Medicinal Chemistry In Silico Identification and Analysis of Drug Resistant Mutants of ABL Tyrosine Kinase Based on Detrimental Missense Mutations
Current Signal Transduction Therapy New Drugs, Therapeutic Strategies, and Future Direction for the Treatment of Pulmonary Arterial Hypertension
Current Medicinal Chemistry Clinical Pharmacogenetics of Methotrexate
Current Drug Metabolism Characterizing the Relationship Between the Chemical Structures of Drugs and their Activities on Primary Cultures of Pediatric Solid Tumors
Current Medicinal Chemistry Morpho-Functional Features of In-Vitro Cell Death Induced by Physical Agents
Current Pharmaceutical Design Iron Chelators: Development of Novel Compounds with High and Selective Anti-Tumour Activity
Current Drug Delivery The Novel Role for Lyn in Integrin Signaling in Human Disease
Current Signal Transduction Therapy